leisure time -WSS

leisure time

author：comprehensive 2025-10-01 10:57:15 - browse：33665

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

focus

WSS

The new HIV moral panic

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

UPS workers' union leader explains what's at stake as strike edges closer

Drinking water from half of US faucets contains PFAS: Study

hotspot

leisure time

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

North Korean leader's powerful sister says warplanes repelled US spy plane

In Memoriam: Notable people who died in 2023

Care demand spikes challenge UnitedHealth’s provider arm

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Congress likely to miss an opportunity to fix drug shortages issue

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Celiac disease study examines precisely how gluten triggers injury

As demand for Covid shots wanes, Moderna seeks its next success

Blood tests recalled over risk of missed heart attack diagnosis

entertainment

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

J&J expands global access to TB drug amid advocacy campaign

Neutralizing antibodies against HIV shows promise in children

Who gets to use the title 'doctor'?

The new HIV moral panic

focus

focus

focus

knowledge